z.vogel

TL2 · Nairobi

Contributes reviews on supplier material. Based in Nairobi.

Joined 9 October 2024 · last posted 2d

90 posts, newest first. Showing up to 150.

Second pass at: Absence of evidence and evidence of absence Replied, post #55 · Research Methods › Statistics · 26 Jul 2026 · 15 likes Answering the question post #51 raises rather than the one it answers. Before the thread moves on from Absence of evidence — what is the sample size behind the claim? I…
Fasting versus non-fasting and which tests care Replied, post #71 · Clinical › Bloodwork · 16 Jul 2026 · 7 likes Picking up post #68: that is the part I would want checked first. My experience of fasting versus non-fasting contradicts the reply above. I am posting it as a data…
Reconstituting a multi-strength kit without mixing yourself up — what changed since Replied, post #40 · Practice › Reconstitution · 13 Jul 2026 · 0 likes No disagreement from me. Posting only so the question does not look ignored.
What would change my mind about repair peptides: a specific answer Replied, post #23 · Compounds › Repair & healing peptides · 12 Jul 2026 · 0 likes Narrowing post #21, because the general version has more than one answer. The pentadecapeptide sequence is short and stable enough to survive conditions that would…
Request: a per-category review queue Replied, post #95 · Meta › Feature requests · 11 Jul 2026 · 10 likes The confident answers on per-category review queue and the well-sourced answers are not the same answers, which is the most useful thing I have learned reading this…
Injecting into an area that has become firm: why not to Replied, post #88 · Practice › Administration · 17 Jun 2026 · 14 likes The arithmetic in post #87 is right; the assumption feeding it is the part to check. Leave real distance between consecutive sites rather than moving a centimetre.…
Micronutrient adequacy at low total intake Replied, post #91 · Nutrition & Training › Protein & intake · 14 Jun 2026 · 0 likes Picking up post #90: that is the part I would want checked first. Fibre: adequate fibre intake supports fullness and gut motility, both of which matter during the…
Coming back to: Payment method and the leverage it gives you, ranked Replied, post #3 · Sourcing › Payments · 9 Jun 2026 · 19 likes Helpful, and easy to find again, which is half of what a good reply is.
Tesamorelin has an approved indication — what that changes about the evidence Replied, post #13 · Compounds › Secretagogues & GH axis · 6 Jun 2026 · 0 likes Picking up post #12: that is the part I would want checked first. Evidence quality in the secretagogue literature is honestly weaker than in the incretin literature.…
Mass error in ppm: the arithmetic and the caveat — a second dataset Replied, post #6 · Analytics › Mass spectrometry · 5 Jun 2026 · 2 likes Nothing to add, except that this is the answer I would give if asked.
Reading a home test result without over-claiming Replied, post #67 · Analytics › Home & field testing · 5 Jun 2026 · 28 likes I had written a reply contradicting post #63 and deleted it. Here is what survived. Weighing vials against declared fill is the most underrated home check available. It…
Hair shedding at month three: mechanism and time course — the long version Replied, post #21 · Practice › Side effects · 2 Jun 2026 · 7 likes Fatigue: commonly reported, frequently multifactorial. It is worth asking whether other factors have changed (sleep, training volume, diet adequacy, hydration) before…
Washout with a one-week half-life: the arithmetic — does this still hold? Replied, post #23 · Research Methods › N-of-1 designs · 2 Jun 2026 · 0 likes This follows post #22 rather than contradicting it. A note on how Washout gets discussed rather than on Washout itself: the confident posts get the replies and the…
Second pass at: What a 2 ppm match establishes, and what it does not Replied, post #21 · Analytics › Mass spectrometry · 31 May 2026 · 10 likes Since 2 ppm match keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone with more direct experience…
Coming back to: A newcomer's list of things that confused me, and the fixes Replied, post #7 · Start Here › Welcome · 29 May 2026 · 5 likes The category structure looks heavier than it is. There are twenty top-level categories and you will use three of them. Find those three, mute the rest for a month, and…
Reference intervals: how they are constructed and why one in twenty flags Replied, post #102 · Clinical › Bloodwork · 23 May 2026 · 8 likes I read post #100 twice before replying, because I had assumed the opposite. If you are new and reading this thread for the answer to reference intervals: the answer is…
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #50 · Evidence › Preprints · 11 May 2026 · 2 likes Everything in post #47 holds. The case it does not cover is the one I have. Author track record is a weak signal and it is a signal. A group that has published…
Designing a personal experiment that could change your mind — one year on Replied, post #44 · Research Methods › N-of-1 designs · 10 May 2026 · 16 likes Since Designing a personal experiment keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone with…
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #54 · Start Here › Welcome · 9 May 2026 · 0 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
Request: show the solution author in the topic list — what changed since Replied, post #24 · Meta › Feature requests · 1 May 2026 · 6 likes Fair. Then under the name, at a smaller size, permanently.
Converting between mg/mL and units per dose, both directions — the long version Replied, post #8 · Practice › Reconstitution · 17 Apr 2026 · 4 likes That is a cleaner way of putting what I was circling around.
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #30 · Outcomes › Progress reports · 11 Apr 2026 · 1 like Picking up post #27: that is the part I would want checked first. If a pattern survives a rolling-mean treatment it is worth explaining. Most do not, and that is the…
Second pass at: Leak-back after withdrawal and whether you lost a meaningful dose Replied, post #6 · Practice › Administration · 25 Mar 2026 · 0 likes I would call the community position on Leak-back likely rather than established, and I would be comfortable defending that hedge.
Journal club: LEADER as the historical anchor Replied, post #47 · Evidence › Journal club · 16 Mar 2026 · 14 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
Revisiting: Maintainer handover: how it works Replied, post #53 · Meta › Wiki maintenance · 14 Mar 2026 · 1 like Reading rather than answering, but this is the post I would point somebody at.
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #81 · Practice › Storage & stability · 14 Mar 2026 · 5 likes Storing lyophilised material long term looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in…
The "under review" status pill and when a moderator applies it Replied, post #10 · Evidence › Preprints · 7 Mar 2026 · 0 likes What changes between preprint and publication: authors respond to reviewer comments, re-analyse data, correct errors found in peer review, and sometimes report…
Run-in periods and the population they select Replied, post #73 · Evidence › Trials · 27 Feb 2026 · 0 likes Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical magnitude. The event rate in each arm and the difference between…
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #107 · Documentation › Wiki requests · 24 Feb 2026 · 0 likes Fair, and the limits you put on it are the part I will remember.
What a certificate commits its issuer to — one year on Replied, post #19 · Analytics › COA interpretation · 17 Feb 2026 · 5 likes Reading old certificates: if a certificate is dated years ago, the lot it describes might be old. That is not automatically a problem but it is worth noting. Fresh…
Injection volume, overload, and peak distortion — one year on Replied, post #5 · Analytics › HPLC & UHPLC · 13 Feb 2026 · 23 likes The opening post put the caveat in the right place and I want to underline it. Detection wavelength: 214 nm detects the peptide bond and is relatively insensitive to…
[2026 update] A rising related-substance total over six months: degradation or method… Replied, post #29 · Analytics › Impurities & related substances · 13 Feb 2026 · 25 likes Racemisation produces a diastereomer that is mass-identical and chromatographically resolvable only on a method chosen for the purpose. Standard reversed-phase…
How to ask about something you suspect is a bad idea Replied, post #49 · Start Here › How to Ask · 28 Jan 2026 · 0 likes Coming back to post #46, because the follow-up matters more than the original answer. A photograph of a vial is rarely useful and a photograph of a document usually is.…
Reading an interaction checker output critically Replied, post #97 · Practice › Interactions · 20 Jan 2026 · 18 likes No disagreement from me. Posting only so the question does not look ignored.
A plateau that disappeared when I changed how I measured Replied, post #3 · Outcomes › Progress reports · 19 Dec 2025 · 1 like Reading back through the plateau threads from last year, the same three questions come up every time and only one of them has ever been answered properly. That seems…
A history of disordered eating: proceeding carefully Replied, post #22 · Wellbeing › Mental health · 7 Dec 2025 · 4 likes An honest declaration on history of disordered eating: I have a prior here and it is strong enough that you should weight what I say downward. Stating it rather than…
The headache that turns out to be dehydration Replied, post #82 · Nutrition & Training › Hydration & electrolytes · 5 Dec 2025 · 4 likes Where a laboratory result exists, quoting it with the reference interval makes the discussion tractable. Without it the thread is guesswork.
Tracking a preprint to publication: a worked example Replied, post #19 · Evidence › Preprints · 1 Dec 2025 · 24 likes Post #18 is right about the mechanism and I think understates the practical bit. Check whether it was later published: searching for the preprint's first author and…
The anatomy of a question that gets answered within an hour — the long version Replied, post #108 · Start Here › How to Ask · 17 Nov 2025 · 3 likes That reframing is the whole thing. The facts I already had.
EMA product information as a primary source Replied, post #48 · Regional › European Union · 9 Nov 2025 · 0 likes Answering the question post #46 raises rather than the one it answers. Where I have landed on EMA product information, having got it wrong once in public: the direction…
Documentation that materially improves an appeal's chances Replied, post #48 · Access › Insurance & coverage · 1 Nov 2025 · 0 likes The denial letter is the specification for your appeal. It states a criterion, and the job is to demonstrate that the criterion is met in the letter's own language.…
A 40-week log with the measurement method stated Replied, post #95 · Outcomes › Progress reports · 29 Oct 2025 · 32 likes Rate of change matters more than the absolute number for most of the questions people ask about their own series. Take it as a starting point and not as a specification.
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #109 · Compounds › Tirzepatide · 24 Oct 2025 · 15 likes Injection-site reactions were reported at a low but non-zero rate across the trials. The practical point is that a reaction at one site does not predict a reaction at…
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #83 · Compounds › Tirzepatide · 22 Oct 2025 · 6 likes Taking post #80 at face value and following it one step further. Research-use-only tirzepatide is not approved for human use and is not made to pharmaceutical…
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #79 · Start Here › Welcome · 20 Oct 2025 · 2 likes One thing that took me a while to notice: the search box indexes maintained documents as well as topics, and documents carry a review date. If a document and a…
Persistent vomiting and the threshold for seeking help Replied, post #53 · Safety › Adverse events · 19 Oct 2025 · 12 likes Where I part company with post #51, and it is a narrow parting. My experience of persistent vomiting contradicts the reply above. I am posting it as a data point rather…
Trial registration and comparing the protocol with the paper Replied, post #45 · Evidence › Trials · 9 Oct 2025 · 3 likes On post #41 — agreed on the reasoning, with one qualification. Entry criteria, run-in periods and the self-selection of people willing to enter a multi-year trial all…
Angle of injection and whether 90 degrees is always right Replied, post #26 · Practice › Administration · 23 Sep 2025 · 0 likes Subcutaneous injection into abdominal tissue, thigh or upper arm is what the licensed labelling in this class describes, and the published comparisons found the…
Second pass at: The mass-error checker and its intended scope Replied, post #17 · Data & Tools › Calculators · 14 Sep 2025 · 23 likes Coming back to post #13, because the follow-up matters more than the original answer. An honest declaration on mass-error checker: I have a prior here and it is strong…
Promotion criteria, and the one that stops most nominations — the long version Replied, post #46 · Documentation › Doc review · 25 Aug 2025 · 3 likes Post #44 put the caveat in the right place and I want to underline it. Second-hand on Promotion criteria, so weight it accordingly — someone whose method I trust told…
Reconstituting a multi-strength kit without mixing yourself up Replied, post #115 · Practice › Reconstitution · 13 Aug 2025 · 3 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does. Posting it…
A ten-fold dose error caught before injection — one year on Replied, post #85 · Devices › Syringes & needles · 3 Aug 2025 · 14 likes Reusing a needle blunts it and there is no benefit to offset that. The second injection with the same needle is the one people describe as painful. This has been…
Column chemistry choices for a 40-residue peptide Replied, post #3 · Analytics › HPLC & UHPLC · 27 Jul 2025 · 0 likes Coming back to the opening post, because the follow-up matters more than the original answer. Detection at 214 nanometres sees the peptide bond and therefore sees…
A field-by-field walk through a certificate of analysis Replied, post #26 · Analytics › COA interpretation · 14 Jul 2025 · 0 likes When method identifiers are missing: "reversed-phase HPLC" is less specific than "reversed-phase HPLC at 214 nm on a C18 column with a 10 to 40% acetonitrile gradient…
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #38 · Access › Insurance & coverage · 8 Jul 2025 · 4 likes On Reading a denial letter the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #82 · Practice › Reconstitution · 6 Jul 2025 · 0 likes Seconded. It reads as careful rather than confident, which is the right register.
What a documentation review can and cannot tell you Replied, post #22 · Sourcing › Independent verification · 3 Jul 2025 · 0 likes Documentation review is a good example of a question where the honest answer is boring and the interesting answers are unsupported. I would go with boring.
Interim analyses and stopping rules — does this still hold? Replied, post #18 · Evidence › Trials · 29 Jun 2025 · 1 like Picking up post #17: that is the part I would want checked first. One more thing on Interim analyses and stopping rules that took me far too long to see: the two…
Whether an aggregate is worth publishing at all: a disputed topic Replied, post #7 · Data & Tools › Datasets · 18 Jun 2025 · 19 likes Self-reported, unblinded, self-selected data has known biases and is still worth collecting, provided every one of those words appears in the description. A…
[2026 update] An appeal that failed, and what I would do differently Replied, post #157 · Access › Insurance & coverage · 17 Jun 2025 · 20 likes Taking post #156 at face value and following it one step further. Reframing appeal slightly, because I think the disagreement is about the question rather than the…
Follow-up: Tracking intake honestly when appetite is absent Replied, post #15 · Nutrition & Training › Protein & intake · 4 Jun 2025 · 8 likes Distribution across the day appears to matter less than total for most outcomes, and it matters practically because a single large meal is harder when appetite is…
Validating a calculator against hand arithmetic — what changed since Replied, post #107 · Data & Tools › Calculators · 2 Jun 2025 · 9 likes Answering the question post #105 raises rather than the one it answers. Reconstitution calculator: enter vial mass, final volume target, and the calculator tells you…
Detection wavelength and why 214 nm and 280 nm disagree Replied, post #2 · Analytics › HPLC & UHPLC · 27 May 2025 · 26 likes Area percent is a proportion of absorbance, not a proportion of mass. Two species with different extinction coefficients at the detection wavelength contribute…
Comparing my trajectory with the trial curves, carefully Replied, post #5 · Outcomes › Progress reports · 14 May 2025 · 2 likes Seconded. It reads as careful rather than confident, which is the right register.
Second pass at: Pen dose counters: what a click does and does not guarantee Replied, post #38 · Devices › Pens & autoinjectors · 12 May 2025 · 5 likes Where I part company with post #37, and it is a narrow parting. Reusability: some pens are single-use (throw away after one injection). Others can be reused until…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #90 · Practice › Reconstitution · 27 Apr 2025 · 9 likes I read post #88 twice before replying, because I had assumed the opposite. Two people can reconstitute the same vial to different concentrations and both be right. The…
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #67 · Clinical › Comorbidities · 25 Apr 2025 · 2 likes Thyroid history and the C-cell finding is the clearest documented contraindication in this class and is specific rather than general. That is one dataset and I would…
Retatrutide dose escalation in the published trials Replied, post #127 · Compounds › Retatrutide · 13 Apr 2025 · 0 likes Retatrutide is investigational. Material obtained outside a clinical trial is research-use-only by definition, is not approved for human use, and carries no assurance…
Hepatic steatosis: what the MASH trial evidence supports Replied, post #17 · Clinical › Comorbidities · 11 Apr 2025 · 0 likes The practical value of this subcategory is helping somebody frame the question they take to an appointment, and that is worth being explicit about. That much is…
Revisiting: Oral versus injected administration claims for BPC-157 Replied, post #14 · Compounds › Repair & healing peptides · 5 Apr 2025 · 10 likes Narrowing post #11, because the general version has more than one answer. Oral versus injected administration claims is worth one more sentence than it usually gets,…
Charge states for a 4 kDa peptide, worked through Replied, post #37 · Analytics › Mass spectrometry · 6 Mar 2025 · 32 likes Trifluoroacetate adducts are common in material purified with TFA and are one reason a mass spectrum from a peptide can look busier than expected. Correct me on the…
Biased agonism: a real phenomenon, an over-used explanation Replied, post #38 · Pharmacology › Receptor biology · 4 Mar 2025 · 0 likes Central versus peripheral action: GLP-1 agonism works through both central nervous system effects (appetite) and peripheral effects (gastric motility, insulin). The…
Reading order for a first week here, and what to skip until later Replied, post #16 · Start Here › Welcome · 26 Feb 2025 · 26 likes The tag pages are usually a better entry point than the categories for a first read. A tag cuts across categories, so following one shows you how the same subject is…
Fibre intake when total intake falls, and the constipation link Replied, post #29 · Nutrition & Training › Protein & intake · 16 Feb 2025 · 1 like Clear enough that I do not think I have a follow-up, which is unusual.
Coming back to: An 18-month record including the parts that went badly Replied, post #10 · Outcomes › Progress reports · 23 Jan 2025 · 18 likes Rate of change matters more than the absolute number for most of the questions people ask about their own series. It took me longer than it should have to see that.
Research-use-only labelling: what it means and what it does not — the long version Replied, post #67 · Sourcing › Regulatory · 19 Jan 2025 · 0 likes Right, and stated more narrowly than I would have dared to state it.
Second pass at: Regression to the mean in progress reports Replied, post #17 · Research Methods › Statistics · 6 Jan 2025 · 0 likes What I can speak to on Regression is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know.
What changed in 2026, by region Replied, post #52 · Access › International · 1 Jan 2025 · 0 likes Post #49 is the version of this I will quote in future. One addition. Licensed prescribing: where a compound is approved, prescribing is restricted to licensed…
Second pass at: Gauge and length selection for subcutaneous injection Replied, post #13 · Devices › Syringes & needles · 27 Dec 2024 · 11 likes Where I part company with post #12, and it is a narrow parting. Speaking only to Gauge and length selection as I have actually seen it, rather than as it is usually…
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #8 · marked as the solution · Compounds › Semaglutide · 16 Dec 2024 · 7 likes Everything in post #6 holds. The case it does not cover is the one I have. Where I have landed on Semaglutide formulation, having got it wrong once in public: the…
A promotion I argued against, and why I lost Replied, post #8 · Documentation › Doc review · 18 Nov 2024 · 0 likes The most useful review comment names a sentence and says what is wrong with it. General approval and general concern are both hard to act on. Someone will know this…
Coming back to: Recording a dissent on a document rather than suppressing it Replied, post #7 · Documentation › Doc review · 18 Nov 2024 · 25 likes Point three stops most nominations. A document without a maintainer becomes wrong quietly, and that is the failure mode the criterion exists to prevent.
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #9 · Compounds › Repair & healing peptides · 7 Nov 2024 · 30 likes This follows post #6 rather than contradicting it. The preclinical work is genuinely interesting and it is preclinical. A rodent tendon model is a model of a rodent…
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #92 · Clinical › Comorbidities · 24 Oct 2024 · 0 likes Post #89 answers the question as asked. The question underneath it is different. If you are new and reading this thread for the answer to Hypertension improvement: the…
Converting between mg/mL and units per dose, both directions Replied, post #61 · Practice › Reconstitution · 23 Oct 2024 · 0 likes Taking post #58 at face value and following it one step further. Swirling until fully clear before drawing is worth the extra minute. A partially dissolved preparation…
Taste changes and food aversion, reported and discussed Replied, post #22 · Practice › Side effects · 23 Sep 2024 · 0 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
Turnaround times and what they mean for a decision — one year on Replied, post #2 · Sourcing › Independent verification · 15 Sep 2024 · 0 likes Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
Cold packs, phase-change material, and what survives ten days Replied, post #46 · Sourcing › Logistics · 26 Jun 2024 · 6 likes Post #45 is right about the mechanism and I think understates the practical bit. Delivery to an address where somebody is present is worth more for cold-chain material…
Promotion criteria, and the one that stops most nominations Replied, post #7 · Documentation › Doc review · 24 Jun 2024 · 4 likes The most useful review comment names a sentence and says what is wrong with it. General approval and general concern are both hard to act on. I have seen it go both…
The mass-error checker and its intended scope Replied, post #30 · Data & Tools › Calculators · 5 Jun 2024 · 0 likes Post #28 answers the question as asked. The question underneath it is different. I keep a log for mass-error checker specifically because my memory of it turned out to…